Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Afsar Waraich

Gastroenterology Aiken, SC Medical Doctor

NPI 1497719975 CMS profile 112764

103 Gregg Ave, Nw, Aiken, SC 29801

Open in the dashboard

General payments

$4,459

252 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Afsar Waraich of Aiken, SC is reported in the CMS Open Payments database as having received $4,459 across 252 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 64th percentile of Gastroenterology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $866 46
2024 General $991 50
2023 General $646 39
2022 General $624 28
2021 General $19 1
2020 General $426 27
2019 General $887 61

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Afsar Waraich
  • Gastroenterology median
  • Middle half of Gastroenterology
  • National median

In program year 2025, general payments to Afsar Waraich were reported at $866. Among 13,050 Gastroenterology profiles paid that year, the median was $639 and the middle half received between $167 and $1,700.

Show as a table
Year Afsar Waraich Gastroenterology median Middle half National median
2019 $887 $417 $126–$1,100 $163
2020 $426 $224 $74–$624 $114
2021 $19 $352 $106–$1,054 $132
2022 $624 $448 $129–$1,270 $149
2023 $646 $533 $150–$1,390 $160
2024 $991 $605 $160–$1,606 $164
2025 $866 $639 $167–$1,700 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AbbVie, Inc. $1,885 111 payments
  2. Takeda Pharmaceuticals U.S.A., Inc. $279 16 payments
  3. Pfizer Inc. $216 15 payments
  4. Lilly USA, LLC $205 11 payments
  5. Janssen Biotech, Inc. $196 12 payments
  6. Salix Pharmaceuticals, a division of Bausch Health US, LLC $178 11 payments
  7. QOL Medical, LLC $171 6 payments
  8. Celgene Corporation $156 10 payments
  9. Daiichi Sankyo Inc. $123 5 payments
  10. UCB, Inc. $100 4 payments
  11. Other $950 51 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $4,377 248 payments
  2. Education $66 3 payments
  3. Consulting Fee $15 1 payment
Products named General payments · program years 2019–2025
  1. LINZESS $529 35 payments
  2. CREON $474 32 payments
  3. RINVOQ $444 26 payments
  4. MAVYRET $421 24 payments
  5. HUMIRA $253 16 payments
  6. SKYRIZI $241 9 payments
  7. OMVOH $205 11 payments
  8. ENTYVIO $194 9 payments
  9. XELJANZ $175 13 payments
  10. ZEPOSIA $156 10 payments
  11. Other $2,194 123 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 24 drugs

Part D claims

1,422

Median for Gastroenterology: 569

Drug cost

$287,005

Median for Gastroenterology: $104,976

Branded share of claims

13.4%

Median for Gastroenterology: 31.8%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Rinvoq Upadacitinib Brand 14 $125,218
Creon Lipase/Protease/Amylase Brand 31 $79,401
Linzess Linaclotide Brand 39 $26,631
Mesalamine Generic 67 $21,527
Balsalazide Disodium Generic 41 $5,971
Budesonide Dr Budesonide Brand 17 $5,400
Mesalamine Er Mesalamine Brand 16 $4,820
Omeprazole Generic 429 $4,191
Pantoprazole Sodium Generic 367 $2,920
Cholestyramine Cholestyramine (With Sugar) Brand 28 $2,527

The 10 drugs with the highest cost, of 24 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 14,294 Part D prescribers listed as Gastroenterology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 25 billing codes

Paid by Medicare

$179,436

Medicare's payments for the services billed

Medicare patients

880

Average age 73

Services billed

1,884

524 women, 356 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 47%
Diabetes 30%
Ischemic heart disease 23%
Chronic kidney disease 22%
Depression 21%
Atrial fibrillation 15%
Cancer 15%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 19 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Sucraid
  • QOL Medical, LLC $126
$126 — —
OMVOH
  • Lilly USA, LLC $94
$94 — —
LINZESS
  • AbbVie, Inc. $68
  • Ironwood Pharmaceuticals, Inc $22
$90 39 —
MAVYRET
  • AbbVie, Inc. $89
$89 — —
ZEPOSIA
  • Celgene Corporation $75
$75 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 19 in the dashboard with a free account

Records

252 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Gastroenterology in South Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record